NCT07447895 Early Pelvic Floor Physical Therapy for Women Undergoing Pelvic Radiation for Gynecologic Malignancies
| NCT ID | NCT07447895 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Cincinnati |
| Condition | Cervical Cancer |
| Study Type | INTERVENTIONAL |
| Enrollment | 28 participants |
| Start Date | 2026-04-16 |
| Primary Completion | 2029-04-16 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 28 participants in total. It began in 2026-04-16 with a primary completion date of 2029-04-16.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This is a single arm phase II study in which 28 patients who will be undergoing definitive pelvic external beam radiation therapy for cervical cancer will receive pelvic floor physical therapy 4 weeks after completing radiation therapy.
Eligibility Criteria
Inclusion Criteria: 1. Participants must be female. 2. Patients must be 18 years old or older. 3. Any patient with invasive cervical cancer who is planned for definitive chemoradiation. 4. Plan to receive a minimum dose of 45Gy to pelvis per investigator. 5. Willing to undergo pelvic floor physical therapy. Exclusion Criteria: 1. Any previous therapeutic pelvic radiation. 2. Non-English speaking.
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07447895 clinical trial?
This trial is open to female participants only, aged 18 Years or older, studying Cervical Cancer. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07447895 currently recruiting?
Yes, NCT07447895 is actively recruiting participants. Contact the research team at cancer@uchealth.com for enrollment information.
Where is the NCT07447895 trial being conducted?
This trial is being conducted at Cincinnati, United States.
Who is sponsoring the NCT07447895 clinical trial?
NCT07447895 is sponsored by University of Cincinnati. The trial plans to enroll 28 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.